Showing results (2281-2290 of 3,277) with videos related to
Sort By:
Pageof 328
Nucleic Acids Research|September 1, 1994
Database of p53 gene somatic mutations in human tumors and cell linesM Hollstein, K Rice, M S Greenblatt, et al.Carcinogenesis|July 1, 1997
Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell linesK Macé, F Aguilar, J S Wang, et al.British Journal of Cancer|July 31, 1998
Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53S Ambs, W P Bennett, W G Merriam, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
TP53 mutation spectrum in lung cancer is not different in women and menAizen J Marrogi, Leah E Mechanic, Judith A Welsh, et al.Oncology Reports|February 9, 2006
Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancerTetsuya Okano, Akihiko Gemma, Yoko Hosoya, et al.Kidney International|March 31, 2007
Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling systemE Parker, L J Newby, C C Sharpe, et al.Cell Reports|December 21, 2022
Kir4.2 mediates proximal potassium effects on glutaminase activity and kidney injuryAndrew S Terker, Yahua Zhang, Juan Pablo Arroyo, et al.Oncogene|April 16, 2013
Possible involvement of LKB1-AMPK signaling in non-homologous end joiningA Ui, H Ogiwara, S Nakajima, et al.Journal of Molecular and Cellular Cardiology|February 5, 2013
Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathyJere Paavola, Simon Schliffke, Sandro Rossetti, et al.Plos One|May 19, 2012
rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancerBríd M Ryan, Andrew C McClary, Nicola Valeri, et al.Pageof 328